Solventum US LLC


Solventum is an independent healthcare company formed from a history of health, materials and data-science solutions. The company develops clinical care products (wound care, IV/sterile management), oral/dental materials and devices, purification and membrane filtration technologies, health information and clinical documentation software, and education and research programs to support clinical evidence and product adoption globally.

Industries

N/A

Nr. of Employees

medium (51-250)

Solventum US LLC


Products

Negative pressure wound therapy systems and consumables

Systems and single-use consumables intended to deliver negative pressure wound therapy and automated instillation therapies for wound management.

Sterilization monitoring indicators

Chemical integrators and rapid-read biological indicators for vaporized hydrogen peroxide and steam sterilization monitoring.

IV site protection products

Products for catheter site coverage, securement and disinfection to reduce IV-related complications.

Dental and orthodontic materials and devices

Professional dental materials (adhesives, cements, composites, impression materials, preventive care products) and orthodontic appliances including aligner and bracket/retainer options.

Membranes and filtration components for OEMs

Membrane materials and filtration components intended for incorporation into OEM applications across medical and industrial uses.

Residential and commercial water filtration systems

Under-sink and whole-house filtration systems to reduce particulates, lead, chlorine taste and odor and other contaminants.

View All Products

Services

Online and in-person courses, webinars and masterclasses for clinicians and technical audiences across medical, oral care, health IT and purification domains.

Support program to foster external clinical and technical research to generate evidence on products and applications.

Secure, web-based portals to place, track and manage therapy orders and related clinical authorizations in a HIPAA-compliant environment.

Product security operations, vulnerability disclosure channels and security bulletins to manage and communicate product security issues.

Customized assessments and guidance to help healthcare facilities define and deliver improved clinical and operational outcomes.

Deployment and integration of ambient clinical documentation and speech-recognition solutions to capture clinician–patient conversations and populate EHR records.

View All Services

Expertise Areas

  • Advanced wound care and negative pressure wound therapy
  • Sterilization assurance and sterilization monitoring
  • Bioprocess purification and downstream processing
  • Membrane and filtration technologies for OEM and water applications
  • Show More (8)

Key Technologies

  • Negative pressure wound therapy
  • Sterilization chemical and biological indicators
  • Membrane filtration technology
  • Filtration and clarification for bioprocessing
  • Show More (8)

News & Updates

Entered into an agreement to acquire a bioscience company focused on engineered materials for regenerative wound care for $725 million in cash plus contingent payments up to $125 million.

Quarterly financial report including sales and outlook updates and a multi-year transformation initiative.

Board authorized repurchase program to purchase up to $1 billion of outstanding common stock.

Quarterly financial results for the period ending March 31, 2024, including capital allocation information.

Company began trading on the New York Stock Exchange following separation from prior parent organization.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.